TY - JOUR
T1 - Optic neuritis and recurrent myelitis in a woman with systemic lupus erythematosus
AU - Birnbaum, Julius
AU - Kerr, Douglas
PY - 2008/7
Y1 - 2008/7
N2 - Background: A 38-year-old woman with systemic lupus erythematosus presented with headaches and bilateral hearing loss. Brain MRI was initially suggestive of small-vessel disease developing in the context of neuropsychiatric systemic lupus erythematosus. Several months later, the patient developed optic neuritis, followed by recurrent attacks of myelitis. Investigations: MRI of the spine revealed multifocal regions of myelitis affecting the cervical spine. Serological evaluation revealed the presence of neuromyelitis optica-IgG antibodies. MRI of the brain was nondiagnostic for multiple sclerosis. Diagnosis: Recurrent myelitis and optic neuritis, occurring in the context of neuromyelitis optica (also known as Devic's syndrome). Management: The patient had recurrent attacks of myelitis despite treatment with pulse cyclophosphamide. After initiation of rituximab, the patient experienced symptomatic improvement and had no further attacks of opticospinal disease.
AB - Background: A 38-year-old woman with systemic lupus erythematosus presented with headaches and bilateral hearing loss. Brain MRI was initially suggestive of small-vessel disease developing in the context of neuropsychiatric systemic lupus erythematosus. Several months later, the patient developed optic neuritis, followed by recurrent attacks of myelitis. Investigations: MRI of the spine revealed multifocal regions of myelitis affecting the cervical spine. Serological evaluation revealed the presence of neuromyelitis optica-IgG antibodies. MRI of the brain was nondiagnostic for multiple sclerosis. Diagnosis: Recurrent myelitis and optic neuritis, occurring in the context of neuromyelitis optica (also known as Devic's syndrome). Management: The patient had recurrent attacks of myelitis despite treatment with pulse cyclophosphamide. After initiation of rituximab, the patient experienced symptomatic improvement and had no further attacks of opticospinal disease.
UR - http://www.scopus.com/inward/record.url?scp=47149106118&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=47149106118&partnerID=8YFLogxK
U2 - 10.1038/ncprheum0818
DO - 10.1038/ncprheum0818
M3 - Article
C2 - 18493269
AN - SCOPUS:47149106118
SN - 1745-8382
VL - 4
SP - 381
EP - 386
JO - Nature Clinical Practice Rheumatology
JF - Nature Clinical Practice Rheumatology
IS - 7
ER -